October 30 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Friday that its standalone net profit fell to 22.1 million levs ($13.2 million/11.3 million euro) in the first nine months of 2020 from 33.5 million levs in the same period of 2019, due to a decrease in revenue.